# GBA Pharma GmbH – FDA Inspection, Oct 12, 2018

Source: https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/30ffd245-ccb0-457d-95fe-52465980c28e
Source feed: FDA_Inspections

> FDA inspection 1070434 of GBA Pharma GmbH, October 12, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1070434
- Company Name: GBA Pharma GmbH
- Inspection Date: 2018-10-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1261571 - 2024-12-11
- [FDA Inspection 865034 - 2013-10-18](https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/0d2c79c2-414b-480f-85b4-702e7dd15250)
- [FDA Inspection 607366 - 2009-07-14](https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/d49a2b54-5008-47bb-b206-50348b28dbdb)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)

Company: https://www.keypedia.com/companies/gba-pharma-gmbh/9493ddfc-e675-4367-ac97-c959ddafdf46

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c